Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults

BACKGROUND: Some vaccines elicit nonspecific immune responses that may protect against heterologous infections. We evaluated the association between recombinant adjuvanted zoster vaccine (RZV) and coronavirus disease 2019 (COVID-19) outcomes at Kaiser Permanente Southern California. METHODS: In a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruxvoort, Katia J, Ackerson, Bradley, Sy, Lina S, Bhavsar, Amit, Tseng, Hung Fu, Florea, Ana, Luo, Yi, Tian, Yun, Solano, Zendi, Widenmaier, Robyn, Shi, Meng, Van Der Most, Robbert, Schmidt, Johannes Eberhard, Danier, Jasur, Breuer, Thomas, Qian, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755259/
https://www.ncbi.nlm.nih.gov/pubmed/34962997
http://dx.doi.org/10.1093/infdis/jiab633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755259/
https://www.ncbi.nlm.nih.gov/pubmed/34962997
http://dx.doi.org/10.1093/infdis/jiab633

Ejemplares similares